New Blood: Former Novartis Exec Transitions to Rubius Therapeutics
New Red-Blood-Cell-Derived Therapies Are Poised to Launch Rubius into the Spotlight.
Improving Human Health: The Promise of Epigenetics
A New Perspective for Genomic Research from Prof. Shankar Balsubramanian
Translating Innovation into Therapies
Antimicrobial Resistance and Drug Commercialization Were Key Topics at the Recent ON Helix Conference in Cambridge, U.K.
Literature Review: Dielectrophoresis to the Fore
Old Methodology Resurrected to Allow Inexpensive Label-Free Separation of Cell Populations
For full access to this article login to GEN Select now.
Moving Microfluidics to the Big Time
Researchers Find New Ways to Bring Microfluidic Devices into Labs and To Point of Care
- The market for microfluidics has experienced tremendous growth over the past few years. Lab-on-a-chip devices for use at the point of care are allowing faster and more portable testing. Other microfluidic devices, for controlling and manipulating sub-microliter volumes of liquid in the laboratory, are saving researchers from needing complex, ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.